Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gelfand, I. M.
Right arrow Articles by Haddad, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gelfand, I. M.
Right arrow Articles by Haddad, N. G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 28:2593-2594, 2005
© 2005 by the American Diabetes Association, Inc.


Letters: Observations

Infancy-Onset Cystic Fibrosis–Related Diabetes

Inessa M. Gelfand, MD1,2, Erica A. Eugster, MD1 and Nadine G. Haddad, MD1

1 James Whitcomb Riley Hospital for Children, Department of Pediatrics, Division of Pediatric Endocrinology and Diabetology, Indiana University School of Medicine, Indianapolis, Indiana
2 Department of Medicine, Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana

Address correspondence to Inessa M. Gelfand, MD, James Whitcomb Riley Hospital for Children, 702 Barnhill Dr., Room 5960, Indianapolis, IN 46202. E-mail: ingelfan{at}iupui.edu

Cystic fibrosis is a genetic disorder characterized by hyperviscous secretions and progressive obstructive end organ damage. Common presentations include meconium ileus, recurrent pulmonary infections, and failure to thrive. Although cystic fibrosis–related diabetes (CFRD) usually presents in the 2nd decade of life, it has been reported in children as young as 2 years (1). Here we present a 7-month-old infant who had CFRD at the time of presentation with cystic fibrosis.

A 7-month-old Caucasian male presented for evaluation of failure to thrive despite adequate intake of high-calorie formula. He was born at term but small for gestational age (birth weight <3rd percentile). Review of systems was significant for a chronic nonproductive cough, three to five loose bowel movements per day, and no history of polydipsia or polyuria. Random blood glucose obtained during a hospitalization for bronchiolitis at 4 months of age was normal. His only medication was multivitamin solution.

At 7 months of age, his weight and length were below the 3rd percentile. Laboratory studies revealed sodium 134 mmol/l (135–145), glucose 119 mg/dl, albumin 2.9 g/dl (3.1–4.7), and sweat chloride 105 mmol/l (0–40). A diagnosis of cystic fibrosis was made. Cystic fibrosis gene analysis revealed homozygous {Delta}F508 mutation.

Pancreatic elastase was <50 mcg EI/g stool (normal >200), consistent with exocrine insufficiency. Salt and pancreatic enzyme supplementations were introduced. Total parenteral nutrition (TPN) with glucose infusion rate of 9.7 mg · kg–1 · min–1 was initiated. The infant developed a marked hyperglycemia (250–559 mg/dl), persistent despite the discontinuation of TPN administration. HbA1c (A1C) was 6.4% (4.0–5.9), and C-peptide 0.6 ng/ml (0.9–4.2) with blood glucose 215 mg/dl. GAD 65, islet cell antibodies (ICA 512), human insulin antibodies, and urinary ketones were negative. Subcutaneous insulin was initiated. The patient was discharged on insulin (0.35 units · kg–1 · day–1) and pancreatic enzyme supplementations and displayed excellent catch-up of linear growth (Fig. 1). At 24 months of age, he required 0.4 units · kg–1 · day–1 of insulin and had A1C of 8.7%.



View larger version (111K):
[in this window]
[in a new window]
 
Figure 1— Growth chart. Arrows represent the initiation of insulin and pancreatic enzyme supplementation.

 
While transient glucose intolerance associated with steroid administration in an infant with cystic fibrosis has been reported (2), to our knowledge our case represents the youngest patient with permanent CFRD ever described. The lack of autoimmunity, continued insulin requirements beyond the age of 18 months, later age at diagnosis, and absence of phenotypic abnormalities (3) effectively exclude type 1 diabetes and transient and permanent neonatal diabetes, respectively.

In conclusion, this case expands the clinical spectrum of CFRD and emphasizes the importance of aggressive nutritional therapy and insulin replacement. Although rare in this age-group, CFRD needs to be considered in clinically unstable children with cystic fibrosis and should be included in the differential diagnosis of non–type 1 diabetes of infancy.

References

  1. Reisman J, Corey M, Canny G, Levison H: Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics 86:374–377, 1990[Abstract/Free Full Text]
  2. Lombardi F, Raia V, Spagnuolo M, Nugnes R, Valerio G, Ciccarelli G, Franzese A: Diabetes in an infant with cystic fibrosis. Pediatr Diabetes 5:199–201, 2004[Medline]
  3. Polak M, Shield J: Neonatal and very-early-onset diabetes mellitus. Semin Neonatol 9:59–65, 2004[Medline]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gelfand, I. M.
Right arrow Articles by Haddad, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gelfand, I. M.
Right arrow Articles by Haddad, N. G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum